SINOPHARM (01099.HK) 0.000 (0.000%) Short selling $18.47M; Ratio 28.007% announced its results for the first quarter ended March 2025, with total operating revenue of RMB141.662 billion, down 3.8% YoY; net profit attributable to equity holders of the parent of RMB1.457 billion, up 2.6% YoY; and EPS of RMB0.47, in accordance with the generally accepted accounting principles of the PRC.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-27 16:25.)